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I.  INTRODUCTION 
“Love you, Mom.”1 Those were the last words Ryan Haight said to his 
mom before he overdosed on a prescription drug he obtained from an 
online pharmacy.2  Ryan Haight never even saw the doctor who wrote his 
prescription for the drugs.3 Worse yet, the creator of the online pharmacy 
and the doctor signing the prescriptions made millions of dollars on their 
scheme before Ryan Haight died.4 Although these individuals have been 
convicted of applicable crimes,5 the nefarious framework facilitating their 
misdeeds remains intact.6 
At the time of his death, Ryan Haight’s mother was a registered nurse 
and his father was a physician.7 His parents’ professional experience with 
prescription medications was one of stringent inventory procedures and 
diligent recordkeeping.8 Therefore, they were shocked at how easily their 
son had acquired prescription medication and were surprised that online 
pharmacies apparently operated with virtually nonexistent standards.9 
 
 1.  Francine Haight, Presentation, Illegal Sales of Pharmaceuticals on the Internet, 
16 ALB. L.J. SCI. & TECH. 565, 566 (2006). 
 2.  Id. 
 3.  Id. 
 4.  Id. at 567; see also DRUG ENFORCEMENT AGENCY, Local Pharmacist and 
Stepfather Sentenced in Internet Pharmacy Case (Mar. 17, 2005), http://www.justice. 
gov/dea/pubs/states/newsrel/dallas031705.html (noting that the pharmacist involved in 
Ryan Haight’s tragedy, Clayton H. Fuchs, made over $8 million dollars operating two 
online pharmacies). 
 5.  U.S. v. Fuchs, 467 F.3d 889, 896, 912 n.2 (5th Cir. 2006) (affirming Clayton 
Fuchs’s appeal of his conviction on six counts—“includ[ing] conspiracy to dispense a 
controlled substance”—following a jury trial and noting that the doctor involved in Ryan 
Haight’s tragedy, Robert Ogle, was not a party to the appeal although he had been 
convicted on two counts—including “conspiracy to illegally distribute a controlled 
substance”—in a jury trial); see also Local Pharmacist and Stepfather Sentenced in 
Internet Pharmacy Case, supra note 4. 
 6.  See infra, Part III-C. 
 7.  Haight, supra note 1, at 566. 
 8.  Id. at 566–67. 
 9.  Id.; see also Kristin Yoo, Note, Self-Prescribing Medication: Regulating 
Prescription Drug Sales on the Internet, 20 J. MARSHALL J. COMPUTER & INFO. L. 57, 60, 
68–69 (2001) (noting that although the NABP has attempted to provide some standards 
for online pharmacies, these standards have not affected a vast number of pharmacies 
because they are not compulsory). 
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Their concerns were not unfounded; according to one report, buying 
prescription drugs online can be just as easy as buying candy online.10 
There is an unaddressed anomaly with respect to regulating online 
pharmacies when compared with traditional pharmacies.11 Online pharmacies 
serve the same ends as traditional brick and mortar pharmacies, i.e., to 
bring medication to consumers as a part of a profitable business. The 
raison d’étre of traditional pharmacy regulation—to protect consumers12 
—should logically apply to online sources of the same inherently dangerous 
pharmaceuticals. However, traditional pharmacies are regulated, while 
online pharmacies have long eluded effective regulation and now constitute 
a lawless source of purchase and abuse that is far from real physician 
control, effective standards, or accountability.13 
Ryan Haight is unfortunately not the only person to have easily obtained 
prescription drugs online and subsequently die from, or experience serious 
problems associated with, the drugs received.14 Thus, there has been a 
diverse call for consumer protection from online pharmacy abuse15 from 
consumer advocacy groups, governments, and applicable experts.16 
Notwithstanding the fact that many experts recognize the problem, 
implementing effective regulations has proven problematic due to inadequacies 
 
 10.  Joseph A. Califano, Jr., NATIONAL CENTER ON ADDICTION AND SUBSTANCE 
ABUSE AT COLUMBIA UNIVERSITY, “You’ve Got Drugs!” Prescription Drug Pushers on 
the Internet: 2006 Update (June 2006), http://static.scribd.com/docs/ed89hyvrez48g.swf? 
INITIAL_VIEW=width.%20From%20us%20pharmacist%20pdf. 
 11.  See Sean P. Haney, Pharmaceutical Dispensing in the “Wild West”: Advancing 
Health Care and Protecting Consumers Through the Regulation of Online Pharmacies, 
42 WM & MARY L. REV. 575, 575 (2000). 
 12.  See id. at 587 (noting that a consumer’s “health safety” is at issue when 
purchasing from some online pharmacies). 
 13.  See generally id.; see also Barbara J. Williams, Note, On-Line Prescription and 
Drug Sales: An Overview of Emerging Issues, 1 HOUS. J. HEALTH L. & POL’Y 147, 148–49 
(2001); see also Bryan A. Liang, A Dose of Reality: Promoting Access to Pharmaceuticals, 
8 WAKE FOREST INTELL. PROP. L. J. 301, 340 (2008). 
 14.  See Illegal Online Pharmacies Providing Faulty Drugs, FORTHEPEOPLE.COM, 
(Oct. 10, 2013), http://www.forthepeople.com/blog/illegal-online-pharmacies-providing-
faulty-drugs (noting that many deaths due to overdosing after obtaining prescription drugs 
online go unnoticed); see also Williams, supra note 13, at 149. 
 15.  See Jeff Karberg, Note, Progress in the Challenge to Regulate Online 
Pharmacies, 23 J.L & HEALTH 113, 114 (2010) (describing a “well documented” need for 
more regulation of online pharmacies). 
 16.  Amy J. Oliver, Internet Pharmacies: Regulation of a Growing Industry, 28 J.L 
MED. & ETHICS 98, 99 (2000).  
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at the national level, coupled with the absence of international controls.17 
This inability to effectively regulate is due in large part to the very nature 
and characteristics of the internet, including anonymity, instantaneous 
communication, jurisdictional obscurity, and the diversity of governing 
bodies involved.18 An emboldened representative of an online pharmacy 
articulated this difficulty by declaring, “I [do not] think the politicians are 
going to be able to do anything to us . . . [it is] kind of like trying to nail 
Jell-O to a wall.”19 
This problem must be addressed immediately and thoughtfully before 
more lives are needlessly ruined or ended. The solution must include an 
evolved understanding of not only the reprehensible elements of some 
online pharmacy operations, but also the legitimate ends that some online 
pharmacies fulfill.20 Also, given the burgeoning international nature of the 
internet, an effective solution to this problem can no longer be restricted 
to just the nation state, it must be a collaborative international effort with 
committed participation from multiple nations.21 
Following this introduction, Part II of this Comment will establish a 
foundation for analyzing the problem by describing online pharmacies in 
the marketplace today. Part III will describe how the international 
community has thus far attempted to address the problem of online 
pharmacies. Part IV will address how the United States has approached 
the problem, including a specific analysis of the strengths and weaknesses 
of the Ryan Haight Online Consumer Protection Act of 2008 (“Ryan 
Haight Act”). Part V will summarize the current problems still facing the 
global marketplace of consumers and citizens. Part VI will recommend a 
solution to the problem in the form of an international compact that draws 
upon the Ryan Haight Act and international approaches to date. Part VII will 
present the objectives and suggested content of such an international 
compact. 
 
 17.  See generally Yoo, supra note 9. 
 18.  Id. at 60; Haney, supra note 11, at 575; see also Kim Zetter, FBI Fears Bitcoin’s 
Popularity With Criminals, WIRED (May 9, 2012 at 10:51PM), http://www.wired.com/ 
threatlevel/2012/05/fbi-fears-bitcoin/ (discussing the potential for bitcoins to facilitate the 
sale of illegal products online, largely due to the anonymity it offers purchasers). 
 19.  John Richard Castronova, Operation Cyber Chase and Other Agency Efforts to 
Control Internet Drug Trafficking, 27 J. LEGAL MED. 207, 213 (2006). 
 20.  CENTERS FOR DISEASE CONTROL AND PREVENTION, Prescription Drug Overdoses: 
An American Epidemic (Feb. 18, 2011), http://www.cdc.gov/about/grand-rounds/archives/ 
2011/01-February.htm. 
 21.  Jeremy W. Hochberg, Nailing Jell-O to a Wall: Regulating Internet Pharmacies, 37 
J. HEALTH L. 445, 468 (2004). 
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II.  BACKGROUND 
A. Types of Online Pharmacies 
Not all online pharmacies are the same, and understanding the differences 
between the various types illuminates the problems they pose.22 Online 
pharmacies are generally classified as a: (1) “traditional online pharmacy,” 
(2) “prescribing-based site pharmacy,” or (3) “rogue pharmacy.”23 The 
main difference among the pharmacies is the extent to which they require 
a prescription or physician-customer interaction. Traditional online 
pharmacies require a prescription issued from a customer’s  physician; 
prescribing-based sites provide a pro forma “cyber-consultation” to 
customers and, subsequently, write the prescription for the customer; and 
rogue pharmacies do not require a prescription at all before dispensing 
prescription drugs.24 
Traditional online pharmacies are functionally similar to traditional 
brick and mortar pharmacies.25 In fact, these pharmacies are often “an 
online extension” of existing well-known brick and mortar pharmacies.26 
As such, they require a prescription from a physician before a customer’s 
order will be processed and completed.27 This prescription must be 
delivered to the pharmacy by the customer or by a physician on behalf of 
the customer.28 Because these pharmacies do not prescribe medication 
themselves, their function is to simply “provid[e] another medium for one 
to fill existing prescriptions.”29 
Aside from properly requiring prescriptions, traditional online 
pharmacies typically implement rigorous self-imposed standards aimed at 
protecting consumers.30 These types of online pharmacies have been 
 
 22.  David Mills, Cybermedicine: The Benefits and Risks of Purchasing Drugs Over 
the Internet, 5 J. TECH. L. & POL’Y 1, para. 5 (2000). 
 23.  Karberg, supra note 15, at 115; Ludmila Bussiki Silva Clifton, Internet Drug 
Sales: Is it Time to Welcome “Big Brother” Into Your Medicine Cabinet?, 20 J. CONTEMP. 
HEALTH L. & POL’Y 541, 546 (2004). 
 24.  Kerry Toth Rost, Note, Policing the “Wild West” World of Internet Pharmacies”, 
76 CHI.-KENT L. REV. 1333, 1334 (2000). 
 25.  Karberg, supra note 15, at 115. 
 26.  Id. 
 27.  Id. 
 28.  Yoo, supra note 9, at 64. 
 29.  Joanna M. Carlini, Note, Liability on the Internet: Prescription Drugs and the 
Virtual Pharmacy, 22 WHITTIER L. REV. 157, 171 (2000). 
 30.  Karberg, supra note 15, at 115. 
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considered “a valuable addition to the healthcare consumer industry.”31 
Accordingly, they are neither part of the online pharmacy problem, nor do 
they warrant the implementation of new regulations.32 
The second type of online pharmacies, prescribing-based site pharmacies, 
presents some problems for consumer safety.33 These pharmacies provide 
both the prescription and the medication to customers who visit the site.34 
The prescription-writing process usually entails a pharmacy providing the 
consumer with a consultation that consists of little more than a 
questionnaire.35 Then, a doctor reviews the results of the consultation and, if 
approved, the doctor writes the prescription.36 There is no actual physical 
examination of the patient in these scenarios, because the entirety of the 
“examination” occurs online.37 
One obvious problem with these types of pharmacies is that online 
questionnaires are simply not comparable to either a thorough medical 
history report or to an actual physical examination.38 Patients can, and 
often do, provide inaccurate information on these questionnaires, a feat 
they would have a harder time accomplishing at a brick-and-mortar 
pharmacy during an in-person examination with a doctor or medical 
professional.39 Furthermore, these questionnaires do not ask the detailed 
or critical questions that are necessary for a proper determination of the 
appropriate medication for a particular ailment.40 
Another problem with prescribing-based online pharmacies is the high 
rate of approval for desired medications, possibly influenced by the fact 
that many consulting doctors employed by this type of online pharmacy 
get paid by the prescription.41 Furthermore, these types of pharmacies may 
 
 31.  Rost, supra note 24, at 1334. 
 32.  Bethany Lipman, Note, Prescribing Medicine For Online Pharmacies: An 
Assessment of the Law and a Proposal to Combat Illegal Drug Outlets, 50 AM. CRIM. L. 
REV. 545, 549 (2013). 
 33.  See Karberg, supra note 15, at 116. 
 34.  Id. 
 35.  See id. 
 36.  Lipman, supra note 32, at 550. 
 37.  Williams, supra note 13, at 151. 
 38.  Mills, supra note 22, at 6. 
 39.  Ann M. Alexander, Buying Drugs over the Internet: Who is Regulating 
Pharmacies on the World Wide Web, 13 SYRACUSE SCI. & TECH. L. REP. 1, 3 (2006); see 
also Hochberg, supra note 22, at 446 (noting that those with addictions to a pharmaceutical 
may go online for the purpose of avoiding the traditional brick-and-mortar physician-
patient interaction). 
 40.  Alexander, supra note 39, at 1. 
 41.  Karberg, supra note 15, at 116; see also Ancier v. State, Dept. of Health, 140 
Wash. App. 564, 568 (2007) (where a doctor reviewed 200,000 prescriptions over the 
course of three years and approved 180,000 of them); United States v. Fuchs, 467 F.3d 
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appear to be legitimate, but the physicians providing the imprimatur are 
not acting in accordance with the accepted standards of the medical 
profession.42 For instance, one website advertised that it had a licensed 
physician reviewing patient questionnaires; however, the website failed to 
mention that his license had been revoked in two states.43 
The third category, “rogue” online pharmacies, poses additional dangers to 
consumers.44 Rogue online pharmacies dispense prescription medications 
without first receiving a prescription, offering a questionnaire,  or 
performing an examination to determine a medical need for the drugs 
sought.45 These sites merely require a prospective customer to fill out an 
order form and select both the drug and quantity desired.46 In order to 
receive the drugs, customers simply pay with a credit card online or 
promise to furnish cash when receiving the drugs.47 
Rogue online pharmacies generally operate illegally, because only 
licensed healthcare practitioners are authorized to dispense pharmaceutical 
drugs, and they must do so in accordance with a valid prescription.48 
Rogue pharmacies may also operate illegally by selling drugs that are 
banned categorically for sale by certain governments.49 As such, they have 
been analogized to street drug dealers50 and are widely considered to be 
extremely dangerous.51 Nevertheless, this third category of online 
pharmacies has proliferated widely.52 
There are currently more than “40,000 active rogue [online] 
pharmacies.”53 Adding to public safety concerns, the World Health 
Organization (“WHO”) has found that up to 50% of the medicine sold on 
 
889, 898 (5th Cir. 2006) (where one pharmacist received $40 per prescription approved 
and another between $40–70 per prescription approved). 
 42.  Lipman, supra note 32, at 550. 
 43.  Williams, supra note 13, at 151. 
 44.  Clifton, supra note 23, at 546. 
 45.  Yoo, supra note 9, at 65. 
 46.  Id. 
 47.  Lipman, supra note 32, at 550. 
 48.  Id. 
 49.  See id. 
 50.  Karberg, supra note 15, at 117. 
 51.  Online Rogue Pharmacies Still Booming, ASSOCIATED PRESS, (Aug. 23, 2007), 
http://www.nbcnews.com/id/20409515/#.UmhOiBbvyqQ. 
 52.  Id. 
 53.  Frequently Asked Questions, LEGITSCRIPT, (last visited Mar. 4, 2015) https:// 
www.legitscript.com/about/faq/. 
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these sites is fake.54 This evidences that consumers are in danger of 
receiving harmful drugs in addition to failing to receive the drugs they 
need.55 
Oversight of rogue internet pharmacies is very difficult, as these sites 
often diversify the locations of their operations.56 For example, one rogue 
pharmacy utilized a domain name registered in Russia, web servers 
located in China and Brazil, processed its expenditures through a bank in 
Azerbaijan, and shipped its products from India.57  Due to the extreme 
risks to patient health posed by “rogue” pharmacies, regulators have, 
understandably, largely focused on this “rogue” type of pharmacy.58 
B. Benefits of Online Pharmacies 
“The beneficial potential of online pharmacies is significant.”59 The 
economic incentive to sell pharmaceuticals online is clear. The global 
pharmaceutical industry earned over $980 billion dollars in revenue in 
2013, up from the $390 billion earned in 2001, and is expected to continue 
growing to just under $1.3 trillion by 2017.60 Additionally, over 2.4 billion 
of the world’s 7 billion inhabitants are internet users.61 Therefore, because 
internet communication costs are essentially negligible, online pharmacies 
are an economically attractive proposition to sellers.62 
Online pharmacies are not only economically attractive from a seller’s 
perspective, but they are also attractive from a buyer’s perspective.63 
These sites often offer consumers lower costs due to increased competition64 
 
 54.  WHO and Partners Accelerate Fight Against Counterfeit Medicines, WORLD 
HEALTH ORGANIZATION, http://www.who.int/mediacentre/news/releases/2006/pr69/en/ 
index.html (last visited Mar. 4, 2015). 
 55.  See id. 
 56.  Yoo, supra note 9, at 66; see, e.g., Liang, supra note 13, at 340 (noting “the 
nature of online pharmacies and the inability of key [U.S.] agencies to provide even 
rudimentary controls over rogue internet pharmacies”). 
 57.  Internet Pharmacies: Federal Agencies and States Face Challenges Combatting 
Rogue Sites, Particularly Those Abroad, GOVERNMENT ACCOUNTABILITY OFFICE (July 
2013), http://www.gao.gov/assets/660/655751.pdf. 
 58.  Lipman, supra note 32, at 550. 
 59.  Haney, supra note 11, at 582. 
 60. Statistics and facts about the pharmaceutical industry worldwide, STATISTA, 
http://www.statista.com/topics/1764/global-pharmaceutical-industry/ (last visited Mar. 4, 
2015). 
 61.  Internet Users in The World Distribution by World Regions—2012 Q2, 
INTERNET WORLD STATS (June 30, 2012), http://www.internetworldstats.com/stats.htm. 
 62.  Clifton, supra note 23, at 541. 
 63.  Rost, supra note 24, at 1337–38; see also Drug Sales Over the Internet, U.S. 
FOOD AND DRUG ADMINISTRATION (June 30, 1999), http://www.fda.gov/NewsEvents/ 
Testimony/ucm115047.htm. 
 64.  Rost, supra note 24, at 1337. 
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and lower overhead.65 Consumers may also benefit from comparative 
shopping, greater availability of drugs, ease of purchase, and convenience.66 
Shoppers also gain the convenience and privacy of ordering drugs online 
and having them delivered directly to their doors.67 And, in terms of 
legitimate functioning, online pharmacies allow “online prescription 
transmission and electronic consults within narrowly defined circumstances,”68 
which may not pose a consumer protection issue in certain circumstances. 
Considering the benefits that online pharmacies may provide to both 
sellers and consumers, it is clear that online pharmacies have the potential 
to provide a significant benefit to global society.69 However, with these 
tremendous benefits comes a great potential for abuse. 
C.  Dangers of Some Types of Online Pharmacies 
Online pharmacies pose dangers for consumers in many different ways, 
as follows: 
(a)  The illegitimate pharmaceutical industry is growing alongside 
the legitimate industry.70 
(b)  It may be very hard for consumers to distinguish between a 
legitimate online pharmacy and an illegitimate or rogue 
pharmacy.71 
(c) Consumers have easy access to low-quality, expired, counterfeit, or 
unapproved drugs.72 
(d)   Online pharmacies have begun implementing persistent advertising 
strategies in an effort to convince patients to self-diagnose their 
medical ailments and purchase drugs they may not need.73 
 
 65.  Castronova, supra note 19, at 209. 
 66.  Id. at 210. 
 67.  Carlini, supra note 29, at 157. 
 68.  Haney, supra note 11, at 583. 
 69.  Yoo, supra note 9, at 62 (recognizing that “legitimate prescription drug sales 
on the internet can provide tremendous benefits to consumers.”). 
 70.  See Counterfeit Medicines, WORLD HEALTH ORGANIZATION (Nov. 14, 2006), 
http://www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index.html  
containing a projection by the Centre for Medicines in the Public Interest that the 
worldwide sale of counterfeit pharmaceuticals would be $75 billion in 2010, an increase 
of 90% from 2005). 
 71.  Rost, supra note 24, at 1338. 
 72.  Castronova, supra note 19, at 211. 
 73.  Id. 
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(e)  Consumers are at a greater risk to have their confidential health 
information mismanaged and their privacy violated when dealing 
with online pharmacies.74 
(f)  Customers utilizing these sites often believe, incorrectly, that 
abusing prescription drugs “cannot be as harmful as abusing 
more conventional ‘street’ drugs.”75 
(g)  Drugs purchased from foreign sites may have incorrect and 
dangerous labeling and packaging.76 
(h)  There may not be a patient-physician relationship.77 
The lack of a physician-patient-pharmacist relationship sticks out as 
being especially troublesome. Before the emergence of online pharmacies, 
prescription drugs were—in the normal course of behavior—not available 
without a physician-patient physical interaction.78  Now, prescribing-
based and rogue online pharmacies do not require this relationship.79 This 
is problematic because, “[n]ot only does the physician have no way of 
knowing the identity of his patient, but in many cases the patient has no 
way of knowing whether the physician or pharmacist with whom he is 
dealing is properly licensed.”80 
Further, customers receiving drugs without a physician-patient 
consultation or relationship are not afforded the same safeguards provided by 
physician and pharmacist reviews.81 Risk is disproportionately allocated 
to these consumers, as they are required to learn on their own about the 
medication they receive, including proper utilization, potential side 
effects, and complications with mixing the medication with other drugs.82 
Essentially, “a patient can skip going to the doctor and can substitute a 
 
 74.  See Karberg, supra note 15, at 132–35. 
 75.  Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act 
of 2008; Final Rule, 74 Fed. Reg. 15,595, 15,596 (Apr. 6, 2009) (to be codified at 21 
C.F.R. pt 1300, 1301, 1304, et. al.), http://www.gpo.gov/fdsys/pkg/FR-2009-04-06/ 
html/E9-7698.htm [hereinafter Implementation of the Ryan Haight Act]. 
 76.  Michael Veronin, Packaging and Labeling of Pharmaceutical Products 
Obtained from the Internet, J. MED. INTERNET. RES. 2011 Jan–Mar. (2011), http://www. 
ncbi.nlm.nih.gov/pmc/articles/PMC3221344/ (recognizing that foreign sites are significantly 
noncompliant with FDA regulations on the labeling and packaging of pharmaceuticals, a 
critical means for patient safety). 
 77.  Mills, supra note 22, at ¶¶ 17, 19. 
 78.  Kara M. Friedman, Internet Prescribing Limitations and Alternatives, 10 
ANNALS H. L. 139, 140 (2001). 
 79.  See Rost, supra note 24, at 1334. 
 80.  Hochberg, supra note 21, at 452. 
 81.  Rost, supra note 24, at 1339. 
 82.  Id. 
SCHULTZ-EICADA (DO NOT DELETE) 10/7/2016  2:39 PM 
[VOL. 16:  381, 2015]  Online Pharmacy Regulation 
  SAN DIEGO INT’L L.J. 
 391 
click of the button for 6 years of medical school”83 and additional years 
of residency training. 
The following two examples vividly illustrate some of the most 
troublesome characteristics of online pharmacies, particularly the ease 
with which drugs may be obtained and the alarming lack of oversight. 
These examples would almost be comical were the life and death 
implications not so glaringly apparent. 
First, an investigative journalist successfully obtained weight loss 
medication from an online pharmacy by inputting the information of a 
seven-year-old child into the website.84 Secondly, another investigative 
journalist obtained Viagra for her cat from an online pharmacy.85 This 
journalist simply filled out a questionnaire with the cat’s information, 
including its exact height (six inches tall) and weight (fifteen pounds).86 
Further, in response to a question about prior surgeries, the journalist 
responded, “Neutered, 12/15/88.”87 
Not only did the pharmacies in these examples fill and deliver such 
ludicrous prescriptions, but they also did not question any of the inputted 
data.88 This suggests neither a physician nor a pharmacist ever reviewed 
these orders in any meaningful sense.89 The nonsensical and glaring 
failures that these two examples exemplify are disconcerting.90 
The negative effects of some online pharmacies are substantial, as 
evidenced by the vast number of people who are getting sick or dying due 
to medications obtained through these types of pharmacies.91 Action must 
be taken to improve the landscape of providing medication online, 
particularly international regulation, as national regulatory regimes 
inherently fall short of realizing a lasting solution due to the glaring holes 
in the regulatory schemes.92 
 
 83.  Carlini, supra note 29, at 173. 
 84.  Castronova, supra note 19, at 207. 
 85.  Id. 
 86.  Williams, supra note 13, at 153. 
 87.  Carlini, supra note 29, at 159. 
 88.  Consumer News, Congressional Panel Discusses Online Pharmacies, 11 LOY. 
CONSUMER L. REV. 212, 213 (1999). 
 89.  Carlini, supra note 29, at 159. 
 90.  See generally id. 
 91.  WHO and Partners Accelerate Fight Against Counterfeit Medicines, supra note 
54. 
 92.  Haney, supra note 11, at 612. 
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III.  INTERNATIONAL APPROACHES 
Many scholars and health organizations have called for a comprehensive, 
unified international approach to regulating online pharmacies, including 
establishing “standardized regulations, operations, and reporting 
infrastructures supported by serious criminal penalties.”93 Nevertheless, 
international approaches to solving the problem of regulating online 
pharmacies have thus far, at best, provided short-term relief, not a lasting 
solution. 
A. World Health Organization 
The WHO has explicitly recognized the potential for selling prescription 
drugs online to evade unilateral regulatory regimes and has noted that this 
poses a problem for consumers worldwide because it makes medical 
products that are “unapproved, fraudulent, unsafe, or ineffective” readily 
available.94 In accordance with this recognition, the WHO has dedicated 
resources to address this problem beginning as early as 1997.95 
For example, at the request of the Fiftieth World Health Assembly, the 
WHO created a group to gather information pertaining to the problems 
associated with online pharmacies.96 This group collected data by 
collaborating with “drug regulatory agencies, national and international 
enforcement agencies, consumer groups, professional associations, and 
the pharmaceutical industry.”97 Subsequently, at the request of the Fifty-
First World Health Assembly, the WHO investigated relevant “existing 
legislation, regulation, and guidelines.”98 
Thereafter, in a further effort to better understand how countries 
regulate the buying and selling of prescription medications online, the 
WHO sent a questionnaire to all 191 of its Member States and received 
responses from 58.99 The results of the questionnaire “give good grounds 
for safety concerns.”100 The WHO received information that only five 
 
 93.  See, e.g., Brian A. Liang, Fade to Black: Importation and Counterfeit Drugs, 
32 AM. J. L. & MED. 279, 312 (2006). 
 94.  Brian A. Liang & Tim Mackey, Searching for Safety: Addressing Search 
Engine, Website, and Provider Accountability for Illicit Online Drug Sales, 35 AM. J. L. 
& MED. 125, 141 (2009). 
 95.  Id. 
 96.  Dr. Lembit Rägo, Overview of activities by the World Health Organization, 
WORLD HEALTH ORGANIZATION 7 (Sept. 24–25, 2001) http://apps.who.int/medicinedocs/ 
pdf/h2960e/h2960e.pdf. 
 97.  Id. 
 98.  Id. 
 99.  Id. at 7–8. 
 100.  Id. at 8. 
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countries “specifically regulate the promotion and sale of pharmaceuticals 
through the internet.”101 
The apparent dearth of national solutions evinced by this questionnaire, 
coupled with the other relevant data the WHO had previously obtained, 
resulted in the WHO’s attempt to provide Member States with templates 
capable of being implemented locally.102 These templates include an 
informational guidebook and a draft website for drug regulatory 
authorities.103 
Specifically, the WHO guidebook, entitled Medical Products and the 
Internet: A Guide to Finding Reliable Information, serves as an 
educational tool for nations to present to their citizens.104 The guidebook 
seeks to educate consumers on a variety of topics, including being able to 
locate warning signs on online pharmacies, such as: (1) advertisements 
that claim scientific breakthroughs, (2) advertisements claiming to be the 
exclusive source for a drug (and that it can only do so for a limited time), 
and (3) statements that the drugs pose no risks whatsoever.105 The 
guidebook also includes a top-ten list of how prescription drugs can be 
dangerous and ways consumers can spot a legitimate online pharmacy.106 
This list includes tips about what to look for, including active ingredients, 
instructions on proper use, and warnings about possible negative side 
effects.107 
The WHO has also endeavored to educate consumers worldwide about 
purchasing drugs online via its cooperation with the International 
Conference of Drug Regulatory Agencies (“ICDRA”).108 ICDRA 
conferences provide a forum for the regulatory bodies of the WHO 
Member States to share information and collaborate with one another 
 
 101.  Id. 
 102.  Id. 
 103.  Id. 
 104.  Ivette P. Gomez, Note, Beyond the Neighborhood Drug Store: U.S. Regulation 
of Online Prescription Drug Sales by Foreign Business, 28 RUTGERS COMPUTER & TECH. 
L.J. 431, 454–55 (2002). 
 105.  Id. at 455. 
 106.  Id. 
 107.  Id. 
 108.  Liang & Mackey, supra note 94, at 143. 
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about how to regulate online pharmacies.109 The goal of these conferences 
is ultimately to harmonize regulations.110 
The WHO has taken more directed action through the WHO International 
Medical Products Anti-Counterfeiting Taskforce (“IMPACT”).111 IMPACT 
“aims to build coordinated networks across and between countries in order 
to halt the production, trading, and selling of fake medicines around the 
globe.”112 Comprised of “international organizations, non-governmental 
organizations, enforcement agencies, pharmaceutical manufacturers 
associations, and drug and regulatory agencies,” IMPACT recognizes the 
need for “an international multi-stakeholder” coordinated approach to 
solve these problems and protect consumers.113 IMPACT presents “guiding 
principles for model legislation” to help countries better align their laws 
with the policy of punishing or deterring this activity.114 
B.  Internet Healthcare Coalition 
Another international organization that has attempted to combat the 
negative effects of online pharmacies is the Internet Healthcare Coalition 
(“IHC”).115 The IHC is an international non-profit organization that consults 
with many government agencies and holds a yearly conference to discuss 
the problems regarding, inter alia, providing prescription medications 
online.116 The specific aims of the organization are to: 1) educate parties 
involved in healthcare about providing healthcare online, 2) provide 
“models . . . of good and bad sources of online healthcare information and 
services,” 3) promote pre-existing resources and create new resources 
pertaining to providing healthcare online, and 4) serve “as a 
representative . . . before public policymakers and with the media.”117 The 
IHC has become a “global leader” in educating people about using the 
internet for healthcare purposes.118 
 
 109.  International Conference of Drug Regulatory Authorities, WORLD HEALTH 
ORGANIZATION, http://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/ 
en/. 
 110.  Id. 
 111.  Liang & Mackey, supra note 94, at 143. 
 112.  About Us, INTERNATIONAL MEDICAL PRODUCTS ANTI-COUNTERFEITING TASKFORCE,  
http://www.who.int/impact/about/en/. 
 113.  Id. 
 114.  WHO and Partners Accelerate Fight Against Counterfeit Medicines, supra note 
54. 
 115.  Gomez, supra note 104, at 456. 
 116.  John Mack, The Internet Healthcare Coalition, U.S. NATIONAL LIBRARY OF 
MEDICINE NATIONAL INSTITUTES OF HEALTH (Mar. 5, 2000), http://www.ncbi.nlm.nih. 
gov/pmc/articles/PMC1761844/. 
 117.  Id. 
 118.  Gomez, supra note 104, at 457. 
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In 2000, the IHC partnered with other organizations to formulate the “e-
Health Ethics Initiative” (“the Initiative”).119 The purpose of the Initiative 
was to “creat[e] a universal ethical code of conduct for health and medical 
websites.”120 The Initiative aimed to enable consumers to make better and 
more informed decisions by generating information that would help 
consumers understand the statements online pharmacies present on their 
websites.121 
C. INTERPOL 
INTERPOL has also recognized the problems of illicit online pharmacies 
and has created many task forces aimed at the enforcement of crimes, 
global education, and cooperation.122 For instance, one of INTERPOL’s 
flagship operations, Operation Pangea, is dedicated to targeting and 
intervening against the sale of illegal drugs online.123 The operation conducts 
one mission annually consisting of a week of coordinated efforts among 
“customs, health regulators, national police, and the private sector.”124 
Operation Pangea achieves its success by targeting the following: “internet 
service providers, payment systems, and the delivery service” utilized by 
illegal online pharmacies.125 
Although only ten countries participated in the operation’s inaugural 
year, 2008, the most recent phase in 2013 brought together about 100 
countries.126 There have been six phases of Operation Pangea to date and, 
collectively, they have identified and shut down a great number of 
websites engaged in illegal activity and have resulted in multiple arrests 
of those affiliated with the sale of illegal drugs online.127 
In the most recent phase of Operation Pangea, Pangea VI, INTERPOL 
confiscated 10.1 million illicit and counterfeit pills worth about $36 
 
 119.  Id. 
 120.  Id. 
 121.  Id. 
 122.  See Judy Siegel-Itzkovich, Global Crackdown on Illicit Online Pharmacies, 
PERMANENT FORUM ON INT’L PHARMACEUTICAL CRIME (July 2, 2014), http://pfipc.org/news1/9-
global-crackdown-on-illicit-online-pharmacies. 
 123.  Operations, INTERPOL, http://www.interpol.int/Crime-areas/Pharmaceutical-crime/ 
Operations/Operation-Pangea (last visited Jan. 13, 2013). 
 124.  Id. 
 125.  Id. 
 126.  Id. 
 127.  See id. (providing information about each Operation Pangaea mission to date). 
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million dollars, destroyed over 13,700 websites, either investigated or 
arrested about 213 individuals, and inspected over 500,000 packages, 
resulting in the confiscation of 41,000.128 Major market players were 
involved in Pangea VI, including the United States, the United Kingdom, 
China, India, Japan, and Canada.129 
In addition to Operation Pangea, INTERPOL has recently established 
another unit, the Medical Products Counterfeiting and Pharmaceutical 
Crime unit (“MPCPC”), which is designed to engage in the international 
enforcement of illicit online pharmacies.130 This unit was created to 
support WHO-IMPACT in combatting online pharmaceutical crime.131 
D. National Association of Boards of Pharmacy 
There are also smaller organizations dedicated to educating consumers 
about illegal online pharmacies.132 One such organization is the National 
Association of Boards of Pharmacy (“NABP”).133 The NABP has been 
active in addressing the problems associated with online pharmacies. For 
instance, the NABP maintains a database with information about pharmacies 
and pharmacists.134 Additionally, the NABP hosts a global certification 
program—Verified Internet Pharmacy Practice Site (“VIPPS”)—that 
verifies online pharmacies as being legitimate.135 The purpose of the VIPPS 
program is to put consumers on notice that an online pharmacy with a 
VIPPS certification has passed an independent inspection.136 
This VIPPS program was established due to mounting public concern 
about the problems online pharmacies may pose to consumers, and it 
allows online pharmacies to boast a seal of approval on their website, should 
they satisfy the VIPPS requirements.137 These requirements include 
“compliance with standards of privacy and authentication and security of 
 
 128.  Id. 
 129.  International Operation Targets Online Sale of Illicit Medicines, INTERPOL 
(June 27, 2013), http://www.interpol.int/News-and-media/News-media-releases/2013/PR077 
(last visited Jan. 13, 2014). 
 130.  INTERPOL applauds Southeast Asia Operation Storm II’s Success in Disrupting 
Trade of Counterfeit Medical Products, INTERPOL (Jan. 27, 2010), http://www.interpol. 
int/News-and-media/News-media-releases/2010/PR007. 
 131.  Id. 
 132.  See, e.g., Who We Are, ALLIANCE FOR SAFE ONLINE PHARMACIES, http://safeonlinerx. 
com/about-us/who-we-are/ (last visited Jan. 13, 2014). 
 133.  See About, NATIONAL ASSOCIATION OF BOARDS OF PHARMACY, http://www. 
nabp.net/about (last visited Jan. 13, 2014). 
 134.  Williams, supra note 13, at 181. 
 135.  Id. at 181–82. 
 136.  Castronova, supra note 19, at 220. 
 137.  Oliver, supra note 16, at 99. 
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prescriptions, adhere[nce] to quality assurance policy, and provid[ing] 
meaningful consultation between patients and pharmacists.”138 
Currently, there are thirty-five VIPPS certified pharmacies, eleven of 
which require membership in order to obtain medication, while the 
remaining twenty-four are open to all customers.139 Although this program 
was the first attempt to establish a set of minimum standards for the online 
pharmacy industry, its effect has not been very successful, because 
participation is voluntary140 and stricter regulation is needed.141 
The NABP is also responsible for a more recent development in the 
international approach to regulating online pharmacies.142 The NABP 
proposed to establish and become the official registry for a new domain 
name for buying pharmaceutical medications online, so that consumers 
can be confident in the safety of the drugs they are obtaining.143 NABP 
promulgated this suggestion at the 2013 International Pharmacy 
Federation World Congress, where it further explained the uniform 
domain—“.PHARMACY.”144  The uniform domain would ensure that 
accepted pharmacies “meet all the applicable regulatory standards . . . in 
the jurisdictions where they are based and where they serve patients.”145 
These oversight standards would include “pharmacy licensure, drug 
authenticity, and valid prescription requirements.”146 
However, this proposal has faced a strong opposition that seeks to 
prevent it from being implemented.147 Among the opponents to NABP 
 
 138.  VIPPS, NATIONAL ASSOCIATION OF BOARDS OF PHARMACY, http://www.nabp. 
net/programs/accreditation/vipps (last visited Jan. 13, 2014). 
 139.  Find a VIPPS Pharmacy Online, NATIONAL ASSOCIATION OF BOARDS OF 
PHARMACY, http://www.nabp.net/programs/accreditation/vipps/find-a-vipps-online-pharmacy/ 
(last visited Jan. 13, 2014). 
 140.  Yoo, supra note 9, at 69. 
 141.  Alexander, supra note 39. 
 142.  See NABP Shares Online Pharmacy Safety Information at International 
Pharmaceutical Federation World Congress, NATIONAL ASSOCIATION OF BOARDS OF 
PHARMACY (Sept. 18, 2013 5:40 PM), https://www.nabp.net/news/nabp-shares-online-
pharmacy-safety-information-at-international-pharmaceutical-federation-world-congress. 
 143.  Id. 
 144.  Id. 
 145.  .PHARMACY and NABP, NATIONAL ASSOCIATION OF BOARDS OF PHARMACY,  
http://www.nabp.net/programs/pharamcy/pharmacy-and-nabp (last visited Jan. 13, 2014). 
 146.  Id. 
 147.  See, e.g., Public Citizen, Demand Progress and RXRights.org Join Others 
Opposing U.S. Pharmacy Industry Group From Controlling “Pharmacy” Domain Registration, 
PRWEB (May 30, 2013), http://www.prweb.com/releases/oppose/NABP-ICANN/prweb 
10780126.htm. 
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controlling the “.PHARMACY” domain are Public Citizen, Demand 
Progress, and RxRights.org.148 These opponents of NABP’s proposal 
claim the operation will sacrifice consumer access to affordable medication 
in order to benefit pharmaceutical companies.149 
E. Conclusion About International Approaches 
Although these aforementioned international approaches have seen 
some success, they have not had lasting effects on the online pharmacy 
industry. The problem requires more than education campaigns and short 
bursts of sporadic enforcement. Without re-directed efforts, there are still 
too many avenues for online pharmacies to exploit. 
IV.  UNITED STATES APPROACH 
A.  Background 
The United States presents a domestic regulatory scheme illustrative of 
a unilateral, national approach to regulating online pharmacies. Traditionally, 
each state individually regulates pharmacies.150 However, online pharmacies 
are regulated largely by the Food and Drug Administration (“FDA”) and 
the Drug Enforcement Administration (“DEA”).151 The FDA regulates 
online pharmacies through the Federal Food, Drug, and Cosmetic Act 
(“FDCA”), while the DEA regulates online pharmacies through the 
Controlled Substances Act (“CSA”).152 Although the two agencies often 
work together, the FDA focuses on what has been categorized as “non-
controlled substances”, while the DEA focuses on what has been categorized 
as “controlled substances.”153 
With this infrastructure in place, the distribution of prescription drugs 
in the United States has been “one of the safest systems in the world.”154 
However, with the emergence of online pharmacies, the United States has 
been forced to change its model and adapt its regulations to accommodate 
 
 148.  Id. 
 149.  Id. 
 150.  Oliver, supra note 16, at 99. 
 151.  Karberg, supra note 15, at 118. 
 152.  Id.  
 153.  Id. 
 154.  Clifton, supra note 23, at 544; but cf. Geoffrey Kabat, Natural Does Not Mean Safe, 
SLATE, http://www.slate.com/articles/health_and_science/medical_examiner/2012/11/herbal_ 
supplement_dangers_fda_does_not_regulate_supplements_and_they_can.1.html (last visited 
Jan. 17, 2014) (recognizing that there are still problems with such regulations, including 
the health risks associated with the exemptions from FDA regulation afforded to “dietary 
and herbal supplements”). 
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the benefits of online pharmacies, while also attempting to eliminate the 
harms.155 
One way in which the DEA has attempted to combat illicit online 
pharmacies was by creating a database named the Automation of Reports 
and Consolidated Orders System (“ARCOS”).156 This program requires 
manufacturers and distributors of pharmaceuticals to provide the DEA 
with information about narcotic substances.157 The goal is to allow the 
DEA to utilize this data to pursue investigative leads where consumers 
were purchasing abnormally high volumes of controlled substances.158 
Furthermore, the DEA implemented the “Internet Distributor Initiative” 
and the “Internet Industry Initiative” in an attempt to make distributors 
accountable for their misdeeds and raise awareness among other parties 
who are involved in the misdeeds, including delivery services and credit 
card companies.159 
These initiatives may have brought about some success.160 A study 
performed by the National Center on Addiction and Substance Abuse at 
Columbia University indicated that rogue internet pharmacies decreased 
25% from 2004 to 2008.161 However, a regulatory framework was needed 
to further combat online pharmacies, and that need that was realized in 
2008 with the passage of the Ryan Haight Online Consumer Protection 
Act of 2008. 
B. The Ryan Haight Online Consumer Protection Act of 2008 
Ryan Haight’s story motivated Congress to amend the Controlled 
Substances Act (“CSA”) by passing the Ryan Haight Online Pharmacy 
Consumer Protection Act of 2008 (“Ryan Haight Act”).162 This piece of 
legislation is essentially the first in the United States to specifically attack 
the problem of online pharmacies.163 The act explicitly prohibits distributing 
 
 155.  See generally Kabat, supra note 154, at 544. 
 156.  Monica Kim Sham, Note, Down on the Pharm: The Juvenile Prescription Drug 
Abuse Epidemic and the Necessity of Holding Parents Criminally Liable for Making Drugs 
Accessible in Their Homes, 27 J. CONTEMP. HEALTH L. & POL’Y 426, 440 (2011). 
 157.  Id. 
 158.  Id. 
 159.  Id. 
 160.  Id. at 440–41. 
 161.  Id. 
 162.  See Karberg, supra note 15, at 114, 122. 
 163.  Id. at 122. 
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controlled substances online without a doctor-patient physical examination.164 
Accordingly, the online pharmacies that already require a doctor-patient 
examination—the traditional online pharmacies—are not targeted, while 
prescribing-based and rogue pharmacies are the subject of the Act.165 The 
purpose of the Ryan Haight Act has been described as a means “to protect 
consumers by ensuring that only legitimate, law-abiding Web sites dispense 
controlled substances via the Internet.”166 
The Ryan Haight Act specifically states, “[n]o controlled substance that 
is a prescription drug as determined under the Federal Food, Drug, and 
Cosmetic Act may be delivered, distributed, or dispensed by means of the 
internet without a valid prescription.”167 A valid prescription is defined as 
“a prescription that is issued for a legitimate medical purpose in the course 
of professional practice by—(i) a practitioner who has conducted at least 
1 in-person medical evaluation of the patient; or (ii) a covering 
practitioner.”168 A covering practitioner is one who: 
conducts a medical evaluation (other than an in-person medical evaluation) at the 
request of a practitioner who—(i) has conducted at least 1 in-person medical 
evaluation of the patient or an evaluation of the patient through the practice of 
telemedicine within the previous 24 months; and (ii) is temporarily unavailable 
to conduct the evaluation of the patient.169 
Moreover, the Ryan Haight Act mandates a new DEA registration for 
online pharmacies.170 This registration allows the DEA to better recognize 
and keep track of the misdeeds of online pharmacies.171 
Not only must an online pharmacy now register with the DEA in order 
to operate legally, but it must also report the amount of controlled substances 
it distributes, by any means, during a given month, if the amount it has 
distributed is above the given threshold requirements.172 The threshold 
requirements are as follows: “(A) 100 or more prescriptions dispensed. 
(B) 5,000 or more dosage units of all controlled substances combined.”173 
 
 164.  Lipman, supra note 32, at 552; Controlled Substances Act (CSA), 21 U.S.C. § 
829(e)(2)(A)(i) (2012). 
 165.   See Sarah Rubenstein, New Bill Targets Rogue Druggists on the Internet, 
WALL ST. J. (Oct. 9, 2008 12:01 AM), http://online.wsj.com/news/articles/SB12235152 
1815117817. 
 166.  Implementation of the Ryan Haight Act, supra note 75, at 15,609. 
 167.  21 U.S.C. § 829(e)(1). 
 168.  21 U.S.C. § 829(e)(2)(A). 
 169.  21 U.S.C. § 829(e)(2)(C). 
 170.  Implementation of the Ryan Haight Act, supra note 75, at 15,599; see also 
Karberg, supra note 15, at 124–25. 
 171.  Karberg, supra note 15, at 124–25. 
 172.  Implementation of the Ryan Haight Act, supra note 75, at 15,601; 21 U.S.C. § 
827(d)(2). 
 173.  21 U.S.C. § 827(d)(2)(A); 21 U.S.C. § 827(d)(2)(B). 
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The Ryan Haight Act also requires an online pharmacy to display 
specific information about its operations on its website.174 First, the online 
pharmacy must post a statement and declaration of compliance with the 
new regulations.175 Second, the online pharmacy must prominently display 
the following information: “[t]he name and address of the pharmacy, [t]he 
pharmacy’s telephone number and email address,” the qualifications and 
contact information of the pharmacist in charge, “[a] list of the states in 
which the pharmacy is licensed to dispense controlled substances,” a 
certificate of registration to distribute controlled substances, the qualifications 
and contract information of the person who will provide medical evaluations 
or issue prescriptions for controlled substances, and a statement of 
notice.176 
The Ryan Haight Act also adds two new crimes to the existing CSA 
regulatory framework.177 Specifically, the Ryan Haight Act provides that, 
“[i]t shall be unlawful for any person to knowingly or intentionally—(A) 
deliver, distribute, or dispense a controlled substance by means of the 
internet, except as authorized by this subchapter; or (B) aid or abet . . . any 
activity described in subparagraph (A) that is not authorized by this 
subchapter.”178 
The Ryan Haight Act also broadens the civil liability for violations by 
allowing states to bring a civil action in federal court.179 Specifically, the 
Act provides, “[i]n any case in which the State has reason to believe that 
an interest of the residents of that State has been or is being threatened or 
adversely affected by the action of [sic] [an] Internet site” may bring an 
action in a federal district court.180 Relief in these instances is not limited 
to equitable damages; legal damages are also available.181 
The DEA attempted to articulate, in a press conference, the most 
important features of the Ryan Haight Act as: 1) requiring at least one 
face-to-face medical examination between a patient and a doctor a prescription 
 
 174.  Implementation of the Ryan Haight Act, supra note 75, at 15,602–03; 21 U.S.C. 
§ 831. 
 175.  21 U.S.C. § 831(a); 21 U.S.C. § 831(e). 
 176.  21 U.S.C. § 831(c). 
 177.  Implementation of the Ryan Haight Act, supra note 75, at 15,602–03; 21 U.S.C. 
§ 841(h) (2010). 
 178.  21 U.S.C. § 841(h). 
 179.  Implementation of the Ryan Haight Act, supra note 75, at 15,602; 21 U.S.C. § 
882(c) (2009). 
 180.  21 U.S.C. § 882(c). 
 181.  See id. 
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for a controlled substance to be valid, 2) requiring a DEA endorsement 
before an online pharmacy may distribute controlled substances online, 3) 
deterring the sale of certain drugs by increasing the penalties associated 
with selling such drugs, 4) prohibiting advertising the illegal sale of 
controlled substances online, 5) requiring an online pharmacy to post 
truthful information about its operation, and 6) allowing a civil state cause 
of action for state attorney generals.182 
1.  Strengths of the Ryan Haight Act 
The Ryan Haight Act is not a perfect example of domestic regulation; 
nevertheless, there are some merits in its approach to regulating online 
pharmacies, as it embraces the right policies and is capable of serving as 
a good model for expansion.183 Although still new in its implementation, 
the Ryan Haight Act has been recognized as having had a significant 
impact on reducing the number of domestic online pharmacies operating 
illegally.184 Specifically, the Ryan Haight Act has had the greatest influence 
on combatting prescribing-based online pharmacies, both through prosecutions 
for noncompliance and through the deterrent effect it has, because of the 
clear message it sends to operators of online pharmacies about what is and 
is not legal.185 In fact, five years after the Ryan Haight Act passed, 
prescribing-based online pharmacies have been “largely eliminated” in 
the United States.186 
Arguably the most prominent strength of the Ryan Haight Act is that it 
requires online pharmacies to obtain a valid prescription in order to 
distribute drugs, which must consist of at least one face-to-face doctor-
patient interaction.187 This requirement, at least in theory, puts an end to 
prescribing-based and “rogue” online pharmacies188 and has led to the 
government prosecuting the operators of such pharmacies.189 Unfortunately, 
although this new requirement is necessary for compliance, it is not 
 
 182.  Congress Passes Ryan Haight Online Consumer Protection Act, DRUG 
ENFORCEMENT AGENCY (Oct. 1, 2008), http://www.justice.gov/dea/pubs/pressrel/pr100 
108.html. 
 183.  Drug Dealers on the Internet: Is the DEA enforcing the Ryan Haight Act?, 
LEGITSCRIPT (June 2011), http://www.legitscript.com/download/LegitScript-DEA-Rogue- 
Internet-Pharmacy-Analysis.pdf (noting that the DEA has not effectively enforced the 
Ryan Haight Act). 
 184.  National Drug Control Strategy, OFFICE OF NATIONAL DRUG CONTROL POLICY 
(2010), http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/ndcs2010.pdf. 
 185.  Lipman, supra note 32, at 553. 
 186.  Id. 
 187.  See Karberg, supra note 15, at 126; 21 U.S.C. § 829 (2009). 
 188.  Karberg, supra note 15, at 126. 
 189.  Lipman, supra note 32, at 553. 
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sufficient because other regulations must be adhered to as well, such as 
the mandate that controlled substances “be issued for a legitimate medical 
purpose by an individual practitioner acting in the usual course of his 
professional practice.”190 
Another strength of the Ryan Haight Act is the requirement that online 
pharmacies register with the DEA, in order to be authorized to dispense 
controlled substances online.191 Such a requirement was previously in 
place for traditional brick-and-mortar pharmacies, and this new requirement 
helps put online pharmacies on “equal footing” with these traditional 
pharmacies.192 Now, unregistered sites are illegal and, thus, the DEA can 
shut down any unregistered site and pursue both criminal and civil legal 
action.193 
A beneficial corollary of this registration requirement is that it can 
simultaneously act as a database for legitimate online pharmacies.194 In 
fact, one commentator has suggested that a list of DEA registered online 
pharmacies can set “the foundation for cooperation with other government 
agencies and business entities while also educating consumers as to the 
legitimacy of the pharmacies they visit online.”195 
Additionally, the Ryan Haight Act’s requirement that each site discloses 
certain information about its operations is a very effective means of educating 
consumers about the legality of the drugs they purchase online.196 The 
disclosure is effective, in part, due to the requirement that the information 
be conspicuously posted.197 
Another strength of the Ryan Haight Act is the notice it gives to 
operators of online pharmacies, physicians, and pharmacists: all pharmacies, 
whether operating online or out of a storefront, are now going to be held 
to the same standards.198 The Ryan Haight Act does this by setting a 
standard “baseline professional conduct” for doctors and pharmacists 
 
 190.  Implementation of the Ryan Haight Act, supra note 76, at 15,599 (referring to 
21 CFR 1306.04(a)). 
 191.  Karberg, supra note 15, at 123–25. 
 192.  Id. at 123 
 193.  Id. at 125; see also Implementation of the Ryan Haight Act, supra note 75, at 
15,599. 
 194.  Karberg, supra note 15, at 125. 
 195.  Id. 
 196.  Id. at 125–26. 
 197.  Id. at 126. 
 198.  Implementation of the Ryan Haight Act, supra note 75, at 15,609–10; see also 
Karberg, supra note 15, at 125–26. 
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participating in the online pharmacy market.199 This notice applies not 
only to the individuals who knowingly have been operating illegal sites, 
but also to those who were under the impression that their online 
prescribing or distribution practices were legitimate.200 Accordingly, all 
involved in the online pharmacy market can no longer expect the disparate 
treatment online pharmacies had been receiving as compared with brick-
and-mortar pharmacies, and they are effectively on notice that the United 
States has recognized the problems associated with illicit online 
pharmacies and has implemented more stringent regulations in response 
to those problems. 
The Ryan Haight Act also features an increase in the severity of 
punishments for violations of the CSA.201 Violators of the Ryan Haight 
Act face criminal penalties that could be double what they were prior to 
the passage of the Ryan Haight Act.202 Furthermore, the Ryan Haight Act 
broadened the scope of civil liability by allowing states to bring a civil 
action on behalf of their citizens if they believe the citizens of their state 
are being negatively affected by an online pharmacy.203 Remedies 
available under such a suit include legal damages and equitable relief.204 
These added penalties are beneficial, as they may deter illicit online 
pharmacy operators or preclude them from continuing their operations or 
starting new ones. 
2.  Weaknesses of the Ryan Haight Act 
Despite its apparent successes, the Ryan Haight Act is not a comprehensive 
safeguard. Its scope is too narrow in addressing only “controlled substances,” 
a small fraction of prescriptions dispensed in the United States.205 This 
confined scope also leaves a gap in consumer protection, vis-a-vis foreign 
pharmacies, and does not protect patient privacy.206 
Non-controlled substances also pose dangers for consumers.207 Non-
controlled substances include a wide variety of prescription drugs, from 
the erectile dysfunction drugs Viagra and Cialis, to the painkiller Celebrex, 
 
 199.  Karberg, supra note 15, at 126. 
 200.  Lipman, supra note 32, at 553. 
 201.  Karberg, supra note 15, at 122–23; see also Congress Passes Ryan Haight 
Online Consumer Protection Act, supra note 182. 
 202.  See Congress Passes Ryan Haight Online Consumer Protection Act, supra note 
182. 
 203.  21 U.S.C. § 882 (2013). 
 204.  Karberg, supra note 15, at 128. 
 205.  Id. at 131–32. 
 206.  Id. 
 207.  Id. at 131. 
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and the muscle relaxant Soma.208 Unfortunately, online pharmacies target 
these and other excluded drugs.209 In particular, drugs with weight-loss or 
erectile dysfunction appeal are internet marketed for the supposed “privacy” 
of the transaction.210 Future regulations must also address non-controlled 
substances, because they pose some of the same quality concerns as many 
controlled substances and are potentially harmful.211 
The same two senators who introduced the Ryan Haight Act to 
Congress, Dianne Feinstein and Jeff Sessions, have voiced their concern 
about the Act’s insufficient scope in Congress.212 These senators have 
unsuccessfully called for the passage of the Online Pharmacy Safety Act 
of 2011,213 which essentially would have broadened the scope of the Ryan 
Haight Act to include regulation of all prescription drugs instead of 
merely addressing non-controlled substances.214 The bill also called for an 
amendment to the FDCA and participation from the Secretary of Health 
and Human Services and the FDA in administering the law.215 
The most serious failure of the Ryan Haight Act is its inability to 
address foreign-based rogue online pharmacies.216 These foreign-based 
rogue sites are the principle offender in the realm of online pharmacies, 
yet the Ryan Haight Act essentially does not address them.217 Not only 
does the Ryan Haight Act not address foreign pharmacies, its effectiveness 
in so doing would be suspect had it attempted to do so.218 
Foreign pharmacies are elusive by their very nature, as they are not 
subject to domestic laws.219 Therefore, the Ryan Haight Act, being that it 
 
 208.  Sarah Rubenstein, New Bill Targets Rogue Druggists on the Internet, WALL ST. 
J. (Oct. 9, 2008), http://online.wsj.com/news/articles/SB122351521815117817. 
 209.  See Karberg, supra note 15, at 138. 
 210.  Id. 
 211.  See id. 
 212.  See Dianne Feinstein, Sessions Call for Stricter Online Pharmacy Rules, 
FEINSTEIN.SENATE.GOV (Dec. 15, 2011), http://www.feinstein.senate.gov/public/index.cfm/ 
press-releases?ID=9ac81372-466a-49e1-9d04-33da43cdb806. 
 213.  See S. 2002 (112th): Online Pharmacy Safety Act, GOVTRACK.US (2011), https:// 
www.govtrack.us/congress/bills/112/s2002#overview (indicating this bill has died in 
committee and is not currently under review by Congress). 
 214.  Feinstein, supra note 212. 
 215.  Online Pharmacy Safety Act, H.R. 4095, 112th Cong. (2012), http://beta.congress. 
gov/bill/112th/house-bill/4095. 
 216.  Lipman, supra note 32, at 553. 
 217.  Liang & Mackey, supra note 94, at 152. 
 218.  See generally id. 
 219.  See Karberg, supra note 15, at 135; see also Liang & Mackey, supra note 94, 
at 150. 
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is a domestic piece of legislation, implicitly has a substantial territorial 
application restriction.220 To enforce such domestic legislation, the United 
States—and any other country for that matter—has little authority 
internationally, other than to request foreign governments get involved.221 
This may be difficult to achieve, as it is possible for a pharmacy to be in 
compliance with the laws of the foreign government in which it has based 
its operations, even if it does not comply with American regulations.222 
Essentially the only impact the Ryan Haight Act has on foreign-based 
rogue internet pharmacies is that there are steeper penalties for  
distributing certain medications.223 However, this impact is greatly 
minimized by the fact that operators of these sites know the likelihood of 
being caught and prosecuted for their behavior is minimal.224 This is 
evidenced by the fact that nearly 97% of online pharmacies are still 
operating in non-compliance with state and federal laws or industry 
standards.225 
The Ryan Haight Act also fails to establish standards that protect patient 
privacy.226 “Identity theft, fraud, and patient privacy” are concerns for any 
internet transaction227 and these concerns are amplified when dealing with 
sensitive information like medical records.228 Thus, the legislature omitted 
what should be a necessary component of any regulation in this area when 
it failed to address patient privacy in the Ryan Haight Act.229 
Rather than protecting consumers, it has also been argued that the “valid 
prescription” requirement provides illicit online pharmacies with another 
opportunity to exploit users.230 As the argument goes, illicit online pharmacies 
may utilize the “valid prescription” requirement as another opportunity to 
charge their customers and collect more money from them.231 
These problems should make American lawmakers realize that effectively 
regulating online pharmacies is an “inherently international crime problem.”232 
 
 220.  See Karberg, supra note 15, at 135; see also Liang & Mackey, supra note 94, 
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 221.  Liang & Mackey, supra note 94, at 150. 
 222.  Phil Ayers, Prescribing a Cure for Online Pharmacies, 72 TENN. L. REV. 949, 
976 (2005). 
 223.  Lipman, supra note 32, at 554. 
 224.  Id. 
 225.  Id. at 560–61. 
 226.  Karberg, supra note 15, at 132. 
 227.  Id. 
 228.  Id. 
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C.  Conclusions About the Approach of the United States 
The Ryan Haight Act has been considered “a much needed first step 
toward meaningful regulation of online pharmacies.”233 Pharmacies in the 
international community could potentially benefit by applying some of the 
underlying principles behind the Ryan Haight Act to continue moving in 
the right direction toward solving the worldwide crisis of online pharmacy 
regulation. 
V.  THE CURRENT PROBLEM 
As illustrated by the United States’ legislation aimed at regulating 
online pharmacies and the international approaches to doing the same, 
there exists a deficiency in effective regulation. Domestic regulations fall 
short, as sovereign States do not have the unilateral ability to regulate 
foreign-based online pharmacies that sell medications to consumers within 
their borders.  Similarly, international regulations fall short because they are 
too focused on education and short-term relief. Accordingly, consumers 
are not being protected, and a more comprehensive and cohesive international 
approach is necessary to prevent the proliferation of an epidemic that has 
already killed thousands of people. 
Before addressing the purpose for which this article was written—to 
recommend a solution to the problems associated with certain online 
pharmacies via the implementation of a comprehensive international 
regulatory regime—the arguments against such a recommendation must 
be noted. 
First, there is an argument that, although illicit online pharmacies have 
destroyed or greatly harmed people’s lives, these same pharmacies have 
also saved lives. For example, an American woman named Nina spoke 
out after the United States government shut down numerous illicit online 
pharmacies.234 Nina had become dependent upon a particular illegal 
online pharmacy after she lost her health insurance and could no longer 
afford to obtain a prescription through conventional means.235 Instead, she 
 
 233.  See Karberg, supra note 15, at 142. 
 234.  Thomas Ginsberg, Online Drug Bust is Casting a Wide Net[:] Some Customers 
with Valid Medical Needs Were Using the Internet Pharmacy. Experts Say Battling Sites 
Will Be Hard, PHILA. INQUIRER (Apr. 22, 2005), http://articles.philly.com/2005-04-22/news/ 
254269851internet-pharmacy-online-pharmacy-internet-site. 
 235.  Id. 
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paid $45 a month for medication she obtained online.236 Completely 
oblivious to the source of the medication, who operated the site, and who 
utilized the site, Nina was unfazed—“[i]t was that or nothing.”237 
Second, there is an argument against regulation due to the principle of 
customer autonomy.238 As the argument goes, consumers should have the 
opportunity to decide for themselves where they obtain their medications 
without governmental interference on behalf of the public good.239 Further, 
“[b]y allowing the market to control prices, free from excessive government 
interference, the result will be cheaper drugs for those who can least afford 
it.”240 
This argument is particularly powerful coming from the elderly,  
impoverished, uninsured, and underinsured who may not be able to see a 
doctor or otherwise obtain the drugs.241 The argument for customer autonomy 
is also strong for people who want privacy with respect to the (embarrassing) 
drugs they wish to obtain.242 
Third, there is an argument that attempts to regulate would only unduly 
burden legitimate online pharmacies and would not affect the troublesome 
pharmacies.243 Regulators are therefore cautioned to tailor their regulatory 
schemes to address the problematic types of pharmacies and be wary not 
to cast too wide of a net that will place obstacles in the way of legitimate 
online pharmacies.244 In fact, it has been suggested that governments 
should allow the natural forces of the online market to establish standards 
rather than establishing their own,245 or focus instead on reducing the 
demand for pharmaceuticals.246 
Lastly, it has been argued that the problems associated with the lack of 
a physician-patient relationship, a driving force being the call for 
 
 236.  Id. 
 237.  Id. The fear that regulating online pharmacies may prevent people like Nina 
from obtaining the prescription medication they need is significantly weakened, at least in 
the United States, by the implementation of the Affordable Care Act. Regardless of the 
ultimate wisdom of the Act, “[m]ore than 16 million people have gained health insurance” 
under it, suggesting that people seeking prescription drugs for legitimate medical purposes 
may have another option besides resorting to illicit online pharmacies and, therefore, will 
not be negatively affected by regulating online pharmacies. See Administration: 16M 
gained health coverage under ObamaCare, THE HILL, (Mar. 16, 2015) http://thehill.com/ 
policy/healthcare/235819-administration-16-million-people-gained-obamacare-coverage. 
 238.  See Lipman, supra note 32, at 562. 
 239.  See id. 
 240.  Alexander, supra note 39. 
 241.  See id.; see also Liang & Mackey, supra note 94, at 130. 
 242.  See Alexander, supra note 39. 
 243.  Williams, supra note 13, at 187. 
 244.  Id. 
 245.  See Carlini, supra note 29, at 161. 
 246.  Castronova, supra note 19, at 221. 
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increased regulation, is misplaced because similar practices occur at 
traditional brick-and-mortar pharmacies.247 Such critics contest that 
doctors prescribing medicine without a face-to-face interaction is not as 
anomalous an occurrence as those pushing for regulation postulate.248 For 
example, many doctors at some point in their career have filled a prescription 
for a close friend or a family member of a longtime patient without actually 
seeing that person.249 Accordingly, those who resist regulating online 
pharmacies accuse doctors who do criticize the practice of issuing prescription 
medications online without face-to-face consultation of engaging in 
“professional protectionism.”250 
Notwithstanding these arguments to the contrary, the rationale for more 
regulation—particularly where targeted at abusive practices—is more 
compelling. Ingestion of erroneous or improper dosages can be an issue 
of life or death. Furthermore, stopping the proliferation of illegitimate 
online pharmacies would curb the irresponsible use of prescription 
medicines. The responsible use of medicine, including proper identification 
and dosage, could lead to global annual savings of up to $500 billion 
dollars annually.251 Such consumer protection should be a legitimate 
concern for governments across the world.252 
Recognizing the problem and the need to address it is not enough, as 
additional issues arise in deciding how to effectively solve the problem. 
What type of international or multinational regulatory regime is appropriate 
and necessary to address this worldwide problem? What type of regulatory 
regime should be implemented? 
VI.   MULTINATIONAL REGULATORY SCHEME 
Many scholars and commentators agree that the solution to the problems 
associated with some online pharmacies must involve international 
cooperation.253 For example, the WHO Coordinator of IMPACT, Dr. 
 
 247.  Mills, supra note 22, at 15 n.68. 
 248.  Id. 
 249.  See id. 
 250.  See id. 
 251.  See INTERNATIONAL PHARMACEUTICAL FEDERATION, https://www.fip.org (last 
visited Jan. 17, 2014). 
 252.  See Liang, supra note 93, at 312–14. 
 253.  See, e.g., Hochberg, supra note 21, at 445; Gomez, supra note 104, at 462; Rost, 
supra note 24, at 1335; Lipman, supra note 32, at 564–65; Yoo, supra note 9, at 86; 
Williams, supra note 13, at 185. 
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Valerio Reggie, stated, “we need to coordinate action at a global level.”254 
Scholars and other commentators are not short on giving this same 
advice.255 For instance, one scholar noted, “[i]n both the short and long 
term, emphasis should be upon compacts, agreements, and accords among 
nations and between federal and state governments inter se.”256 In addition 
to calling for government cooperation, at least one scholar calls for a 
strategy that incentivizes private corporations to cooperate as well.257 
It is clear that the market for illicit pharmaceutical distribution “does 
not respect international lines and hence, neither can efforts to eliminate 
it.”258 However, a multilateral international compact that transforms the 
successes and failures of the Ryan Haight Act into a cohesive and unified 
approach to regulating online pharmacies will effectively give sovereign 
States an opportunity to fill the previously incurable extraterritorial 
deficiencies in local regulation and provide consumers with the protection 
they need. 
VII.  INTERNATIONAL COMPACT 
Ryan Haight became the face of online pharmacy reform in the United 
States. The United States legislation enacted in response to his story 
contains a workable framework for an international compact that 
addresses online pharmacy abuse. The Ryan Haight Act provides the 
content for a compact not only in its text, but also in that which critical 
analysis and hindsight reveal are missing from its text. 
To begin, an international compact based upon the Ryan Haight Act 
(and other approaches to combating online pharmacies) should create a 
uniform body of law that is applicable to all online pharmacies operating 
within the borders of any country that is a signatory to the compact. The 
goal of the compact should be to protect consumers in the global marketplace, 
which will be accomplished through the multilateral enforcement of the 
compact’s provisions.259 
 
 254.  WHO and Partners Accelerate Fight Against Counterfeit Medicines, supra note 
55. 
 255.  See Williams, supra note 13, at 185. 
 256.  Id. 
 257.  Lipman, supra note 32, at 568 (calling for governments to incentivize “payment 
intermediaries, search engines, and other private actors” to do their part). 
 258.  Liang, supra note 93, at 313–14. 
 259.  Effective enforcement of the compact may be most readily obtainable if each 
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domestic legislation. See International Norms and Standards Relating to Disability, 
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The drafters of the compact must be mindful of how the compact will 
affect the different types of online pharmacies. With this in mind, the 
compact should greatly emphasize reducing prescription medications that 
are distributed from rogue online pharmacies. This is a feat that has been 
largely unobtainable to date, and the Ryan Haight Act did not effectuate 
real change in this regard either.260 In addition, the compact should target 
prescribing-based sites, and will feasibly be successful in eradicating such 
sites, just as the Ryan Haight Act did. Traditional online pharmacies 
should be subject to certain compliance measures, but should be the least 
emphasized of the three types of online pharmacies. 
Moving to a more particularized view of the content the compact should 
contain, the underlying standard for the compact should be very similar to 
that of the Ryan Haight Act, but with a scope beyond “controlled 
substances.” The broadened scope should embrace all prescription 
medications distributed online. Thus, the standard should make it illegal 
to “knowingly or intentionally . . . deliver, distribute, or dispense” any 
prescription medications online, or to “aid or abet” such activity, unless 
the activity is performed in accordance with the compact.261 To comply 
with the compact, online pharmacies should at least be required to perform 
the following compliance measures: 1) register, 2) disclose information, 
3) report information, and 4) require at least one doctor-patient in person 
examination. 
First, online pharmacies should be required to register with their 
respective governments, just as the Ryan Haight Act requires registration 
with the DEA in the United States.262 This registration requirement should 
be in place for any online pharmacy regardless of whether or not it 
dispenses medications known in the United States as “controlled substances.” 
Furthermore, a list of all registered pharmacies should be kept on a central 
server that is maintained by, and is available to, all signatories. This 
registration requirement will serve many purposes. It will both aid in 
recognizing (and eliminating) noncompliant online pharmacies and will 
educate signatories’ citizens about which online pharmacies are operating 
legitimately.263 For guidance on registration and maintaining such a 
 
(discussing the ways in which international treaty law may be incorporated into domestic 
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 260.  See Lipman, supra note 32, at 554. 
 261.  See 21 U.S.C. § 841(h)(1) (2010). 
 262.  See 21 U.S.C. §§ 823(f), 841(h)(1) (2010). 
 263.  Karberg, supra note 15, at 125. 
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database, drafters of the compact may look to the NABP VIPPS program.  
However, whereas some criticize the NABP’s VIPPS program for its 
voluntary nature,264 this compact’s registration requirement should be 
mandatory for all online pharmacies operating in a State that is a signatory. 
Second, pharmacies must be required to display certain information on 
their websites, just as provided in the Ryan Haight Act.265 The Ryan 
Haight Act provides a meaningful list of the type of information that 
should be disclosed, and the drafters of the compact should emulate such 
provisions. Further, if such information is properly displayed on an online 
pharmacy’s website, and the website has effectively registered with its 
respective government, a “seal of approval” should be issued for the site 
to display. This will give consumers further indication that the site they 
are ordering prescription medications from is operating legitimately. 
Third, online pharmacies should be required to submit reports to their 
respective governments, similar to the Ryan Haight Act’s reporting 
provision.266 The precise drugs and the quantity offered may be decided 
at a later date. There should be two triggers for mandatory reporting: 
surpassing a total volume of prescription medications dispensed, and 
surpassing a certain amount of “dangerous” substances dispensed. 
“Dangerous” substances would be those that provide some of the effects 
that the Mayo Clinic has identified as the causes of “prescription drug 
abuse,” including getting high, relaxing, and feeding  an addiction.267 
Drugs such as Vicodin, Oxycodone, Hydrocodone, Xanax, Adderall, Viagra, 
and Codeine should be included in such a category.268 
The “dangerous” substance data submissions should also be utilized to 
maintain a database similar to California’s Controlled Substance 
Utilization Review and Evaluation System (“CURES”), which makes 
information about the quantity of controlled substances a patient has 
previously purchased available to physicians and pharmacists.269 The 
international compact should require its signatories to maintain such a 
database and, contrary to the CURES operation, make it mandatory for 
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physicians and pharmacists to inquire into the amount of “dangerous” 
substances a potential online customer has previously acquired to help 
determine the validity and medical necessity of the request.270 
Fourth, registered online pharmacies should be banned from dispensing 
prescription medications without first being presented with a prescription 
that is based upon an in-person doctor-patient examination, just as the 
Ryan Haight Act does.271 The language of the Ryan Haight Act’s similar 
provision should be emulated here as well, including language that allows 
for “covering physician” prescriptions to be issued.272 
In addition to establishing these compliance provisions, there should be 
both criminal and civil penalties implemented for violating the compact. 
There should be penalties not only for the operator of a noncomplying 
pharmacy, but also for the individual knowingly purchasing materials from a 
noncomplying pharmacy. This will deter illicit activities and broaden the 
scope of responsibility. There should also be a framework in place 
facilitating communication and cooperation among signatories to enforce 
these penalties. 
In addition to the Ryan Haight Act, prior international actions should 
be incorporated into the compact as well. Signatories should be required 
to promote existing educational campaigns, including the proliferation of 
the WHO’s Medical Products and the Internet: A Guide to Finding 
Reliable Information. For instance, all online pharmacies registered to 
operate under the compact should be required to include a link to such 
information (and other similar materials) on their websites. Additionally, 
signatories should be required to support INTERPOL’s enforcement 
operation, Operation Pangea, if not already doing so. 
Aside from the content of the compact, its adoption, proliferation, and 
enforcement should be discussed. While all States should be welcome to 
be a signatory, States with large numbers of online pharmacy consumers 
should be targeted to become signatories, because they have the greatest 
need for consumer protection. 
 
 270.  See Robert Glatter M.D., Fighting Prescription Drug Abuse With a National 
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The United States should be at the forefront of promoting the proliferation 
of the compact. As the United States’ domestic regulation forms the basis 
for the compact, it only makes sense that the United States should promote 
the new international standard based thereon. Therefore, the United States 
should be the first to adopt the compact and show to the rest of the world 
its intellectual honesty in trying to solve this problem. The United States 
should call upon its allies and biggest trade partners to become signatories 
as well. 
Aside from the United States acting to promote the adoption of the 
compact, international organizations like the WHO, IMPACT, and the IHC 
should promote its adoption as well. These are particularly well-suited 
avenues through which the compact should be promoted. This is critical 
because the potential impact of the compact increases as the number of 
signatories increases. 
Lastly, such an international compact is feasible and enforceable. Consumers 
participating in the online pharmacy market make their purchases from 
within the borders of a nation state. Similarly, the products they purchase 
are imported into that nation State. Therefore, signatories have two 
distinct points at which they can enforce the compact: purchase and 
importation. For instance, signatories may seize the items imported or 
enforce the illegality of the purchase as outlined by the compact. Further, 
the registration requirement allows signatories to enforce the provisions 
of the compact against any unregistered or noncompliant site, even if the 
site is based in another country, provided that country is also a signatory 
to the compact. 
VIII.  CONCLUSION 
Online pharmacies can be a powerful resource for consumers in an 
increasingly technological and fast paced global economy. However, the 
challenges they present must be dealt with by means of a unified stance 
against their fraudulent operation. This can, and should, be achieved in 
the form of an international compact as described above. The Ryan Haight 
Act was a tremendous step forward not only for the United States, but also 
for the global community. However, unilateral domestic regulations, 
though successful on some level, are inherently inadequate to address the 
core of the problem. The unintended consequence of the Ryan Haight Act 
is that it can serve as a framework by which the international community 
can formulate its own regulatory scheme to combat illicit online pharmacies. 
“Love you, Mom.”273 Ryan Haight’s mother should have had the 
opportunity to hear her son say these words many more times than she 
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did. Now, she says, “I wish that something could be done so that no one 
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